GABA Therapeutics Appoints Mario David Saltarelli M.D., Ph.D. as CEO and CMO
April 07, 2022 16:55 ET
|
GABA Therapeutics, Inc
NEWPORT BEACH, Calif., April 07, 2022 (GLOBE NEWSWIRE) -- GABA Therapeutics, Inc, (“GABA”) a clinical-stage biotechnology company developing novel therapies for anxiety, depression and other...